Happy Valentine's Day!
Here are a few Valentine's wishes.
Roses are CO red.
Violets are cyanotic blue.
Let's hope you're neither already dead,
Nor hypoxic too.
Postmortem blood is red.
And sometimes blue,
And oftentimes green.
And maybe black too.
Decomposed liver is brown.
Decomposed liver is too.
Decomposed kidney is also brown.
Why is everything brown?
Postmortem blood is red.
It may also be blue,
Though it can be black.
It smells horrible, too.
MDMA and cannabis are Schedule I.
LSD is too.
Do they belong?
Let me ask you.
About Me
▼
Things I Have Written
▼
Wednesday, February 14, 2018
Sunday, February 11, 2018
NERD and Rihanna - Lemon
NERD and Rihanna’s song Lemon came across my Spotify list last night. The song came out a few months ago but this was my first time ever hearing it.
"Bath salt...bitin’ speakers in the face..."
Yes, the infamous 2012 Causeway Cannibal bath salts attack is referenced here - the attack that was not ever shown to be “bath salt” related, not to mention even drug related at all.
Here’s a link to the song. It's got a nice beat. Enjoy!
"Bath salt...bitin’ speakers in the face..."
Yes, the infamous 2012 Causeway Cannibal bath salts attack is referenced here - the attack that was not ever shown to be “bath salt” related, not to mention even drug related at all.
Here’s a link to the song. It's got a nice beat. Enjoy!
Friday, February 9, 2018
Kratom Redux
Kratom is back in the news.
Long story short...
During the summer of 2016, the DEA moved to place kratom (mitragynine/7-hydroxymitragynine) into Schedule I of the Controlled Substances Act. Almost immediately there was a massive outcry from advocates of the plant, as well as members of Congress, toxicologists, and physicians. I initially wrote about this here. In an unprecedented move, the DEA rescinded their Notice of Intent in Fall 2016. In the Withdrawal, the DEA stated that they would accept public comment on the scheduling of these substances until December 1, 2016 as well as request a scientific/medical evaluation of the substances from the Food and Drug Administration (FDA). During the approximate 2 month comment period, the DEA received around 20,000+ comments, with near 100% having positive comments on the plant.
The FDA has now released their report on Kratom. If you want to read the 164 page document, you can find it here.
I'm not going to go into much here, because other folks have covered it comprehensively.
Nick Wing, a senior reporter with the Huffington Post, covered the FDA report and methodically looked at the case reports where Kratom was associated with cause of death that were covered in the FDA report. You can find his article here.
Dr. David Kroll at Forbes covered it as well and his excellent work can be found here.
Kratom researchers in academia from across the USA and Canada also penned a letter to the DEA and the White House's newly established Opioid Commission. The letter can be found here.
I highly recommend reading the links as they are all spot on.
When the DEA initially moved to schedule Kratom in summer 2016, I said the move was misguided. And farcical. And that the DEA hadn't thought it completely through.
And after reading the FDA's report, I still believe that.
Long story short...
During the summer of 2016, the DEA moved to place kratom (mitragynine/7-hydroxymitragynine) into Schedule I of the Controlled Substances Act. Almost immediately there was a massive outcry from advocates of the plant, as well as members of Congress, toxicologists, and physicians. I initially wrote about this here. In an unprecedented move, the DEA rescinded their Notice of Intent in Fall 2016. In the Withdrawal, the DEA stated that they would accept public comment on the scheduling of these substances until December 1, 2016 as well as request a scientific/medical evaluation of the substances from the Food and Drug Administration (FDA). During the approximate 2 month comment period, the DEA received around 20,000+ comments, with near 100% having positive comments on the plant.
The FDA has now released their report on Kratom. If you want to read the 164 page document, you can find it here.
I'm not going to go into much here, because other folks have covered it comprehensively.
Nick Wing, a senior reporter with the Huffington Post, covered the FDA report and methodically looked at the case reports where Kratom was associated with cause of death that were covered in the FDA report. You can find his article here.
Dr. David Kroll at Forbes covered it as well and his excellent work can be found here.
Kratom researchers in academia from across the USA and Canada also penned a letter to the DEA and the White House's newly established Opioid Commission. The letter can be found here.
I highly recommend reading the links as they are all spot on.
When the DEA initially moved to schedule Kratom in summer 2016, I said the move was misguided. And farcical. And that the DEA hadn't thought it completely through.
And after reading the FDA's report, I still believe that.